SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-23-014976
Filing Date
2023-02-27
Accepted
2023-02-27 20:35:19
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 2466
  Complete submission text file 0001213900-23-014976.txt   3916
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1177 AVENUE OF THE AMERICAS, FL 40 NEW YORK NY 10036
Business Address
Kapoor Vishal (Reporting) CIK: 0001798946 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39138 | Film No.: 23677831